Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. 2011

Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
Discipline of Paediatrics, Women's and Children's Hospital, Children, Youth and Women's Health Service, and University of Adelaide Discipline of Gastroenterology, 72 King William Road, North Adelaide SA 5006, Australia. michelle.clarke@adelaide.edu.au

Rotavirus vaccine for infants was introduced into the National Immunisation Program in Australia in July 2007. To determine the impact of rotavirus vaccination on gastroenteritis hospitalisations amongst children less than six years of age in South Australia, we conducted a retrospective analysis of hospital admissions over two time periods: 1 May 2005-30 April 2007 (prior to rotavirus vaccination introduction) and 1 May 2008-30 April 2010 (post rotavirus vaccination introduction). The introduction of rotavirus vaccination has been associated with a marked reduction in hospital admissions for serious rotavirus gastroenteritis (RVGE) and all-cause gastroenteritis (ACGE). Following the introduction of rotavirus vaccination in South Australia, there was an 83% reduction in RVGE coded admissions (955 vs 165) and a 48% reduction in ACGE coded admissions (4153 vs 2142) for children aged less than six years. Children less than two years demonstrated the greatest reduction (90%) in RVGE admissions and ACGE admissions (57%). Age-specific RVGE hospitalisation rates decreased from 933/100,000 prior to rotavirus vaccine introduction to 88/100,000 for children less than two years of age. In addition, for gastroenteritis hospitalisations for children aged five years at time of admission (unvaccinated cohort) there was a reduction in the number of RVGE cases (24 vs 4), a reduction in age-specific RVGE hospitalisation rates (65/100,000 vs 11/100,000) and a significant reduction in the proportion of overall gastroenteritis cases which were rotavirus positive (11.5% vs 3.5%), suggesting a positive impact on both unvaccinated and vaccinated children less than six years of age in South Australia.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005759 Gastroenteritis INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER. Gastroenteritides
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
March 2014, Communicable diseases intelligence quarterly report,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
February 2022, Infectious diseases (London, England),
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
April 2023, Vaccine,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
September 2017, Vaccine,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
November 2018, Vaccine,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
January 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
November 2018, Vaccine,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
February 2011, Pediatrics,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
September 2020, BMC infectious diseases,
Michelle F Clarke, and Geoffrey P Davidson, and Michael S Gold, and Helen S Marshall
April 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!